Millicent Drug Patent Portfolio
Millicent owns 2 orange book drugs protected by 4 US patents Given below is the list of Millicent's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12178824 | Orodispersible formulations | 24 Jun, 2041 | Active |
| US8268806 | Pharmaceutical compositions | 19 Mar, 2031 | Active |
| US8957054 | Pharmaceutical compositions | 08 Jan, 2030 | Active |
| US8629129 | Pharmaceutical compositions | 07 Aug, 2028 | Active |
Latest Legal Activities on Millicent's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Millicent.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 06 Jun, 2025 | US8629129 |
| Patent eGrant Notification | 31 Dec, 2024 | US12178824 |
| Recordation of Patent eGrant | 31 Dec, 2024 | US12178824 |
| Recordation of Patent Grant Mailed | 31 Dec, 2024 | US12178824 |
| Email Notification | 31 Dec, 2024 | US12178824 |
| Patent Issue Date Used in PTA Calculation | 31 Dec, 2024 | US12178824 |
| Mail Patent eGrant Notification | 31 Dec, 2024 | US12178824 |
| Email Notification | 11 Dec, 2024 | US12178824 |
| Issue Notification Mailed | 11 Dec, 2024 | US12178824 |
| Dispatch to FDC | 20 Nov, 2024 | US12178824 |
| Application Is Considered Ready for Issue | 20 Nov, 2024 | US12178824 |
| Issue Fee Payment Received | 15 Nov, 2024 | US12178824 |
| Issue Fee Payment Verified | 15 Nov, 2024 | US12178824 |
| Mail Notice of Allowance | 14 Nov, 2024 | US12178824 |
| Notice of Allowance Data Verification Completed | 09 Nov, 2024 | US12178824 |
Millicent's Family Patents
Millicent Drug List
Given below is the complete list of Millicent's drugs and the patents protecting them.
1. Femlyv
Femlyv is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12178824 | Orodispersible formulations |
24 Jun, 2041
(15 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Femlyv's drug page
2. Intrarosa
Intrarosa is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8268806 | Pharmaceutical compositions |
19 Mar, 2031
(5 years from now)
| Active |
| US8957054 | Pharmaceutical compositions |
08 Jan, 2030
(3 years from now)
| Active |
| US8629129 | Pharmaceutical compositions |
07 Aug, 2028
(2 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Intrarosa's drug page